L-Threonine

Quick links

Choose a section

Quick links to important sections

Advertisements

L-Threonine

Advertisements
Advertisements

Treatment option:

Advertisements

Overview of L-Threonine

Property Description
Active Ingredient L-Threonine (L-Thr)
Form Solid (Powder, Tablet, Capsules), Solution
Pharmacological Class Essential Amino Acid, Proteinogenic Amino Acid
Common Use Nutritional support, Protein synthesis
Origin Natural (Bio-fermentation derived)

L-Threonine is an essential amino acid and a fundamental nutrient that the human body cannot produce internally, requiring consistent external intake from diet or supplementation. As a proteinogenic amino acid, its primary function is to serve as one of the 20 crucial building blocks required for synthesizing all human proteins, enzymes, and hormones. It is classified as a nutraceutical or nutritional supplement due to its role in foundational metabolism, a status supported by broad physiological studies and nutritional standards.


What Type of Substance is L-Threonine?

The active compound, L-Threonine (L-Thr), belongs to the high-level Essential Amino Acid class and is chemically defined as (2S,3R)-2-amino-3-hydroxybutanoic acid. L-Threonine is an INN (International Nonproprietary Name) compound often marketed under various brand names as a dietary supplement. The substance is supplied almost exclusively in the L-configuration, which is the optically active, naturally occurring form that the body can readily utilize for protein construction. Only this L-configuration is biologically functional in human protein synthesis.

L-Threonine is typically sourced as a bulk chemical produced via natural bio-fermentation processes. It is generally available for oral consumption in various common dosage forms, including solid preparations such as powder, tablets, and capsules, often marketed for general patient groups seeking nutritional support.


Composition, Forms, and General Purpose

L-Threonine's general purpose is to ensure the body has a sufficient supply of this necessary element to support continuous tissue maintenance and structural integrity, a function well-recognized in nutritional biochemistry. The molecule is vital for forming key structural components like collagen and elastin, and it is also required for the production of mucin, which protects the mucous membranes. Beyond its direct role in structural protein synthesis, L-Threonine serves as a metabolic precursor necessary for the internal creation of the amino acids glycine and serine. By supporting these foundational processes, adequate L-Threonine intake contributes directly to overall nutritional well-being.

Regulatory References

  1. nutritional standards
Advertisements

What side effects are possible with L-Threonine?

Possible Side Effects and Safety Information

The official safety profile for mathbfL-Threonine, an essential amino acid, primarily documents a range of mild to moderate adverse reactions, most frequently affecting the digestive system.

Documented Adverse Reactions by System-Organ Class

Adverse reactions are classified according to the body system affected:

  • Gastrointestinal disorders are common and may include nausea, diarrhea, vomiting, stomach cramps, bloating, and gas.
  • Nervous system disorders are also listed, including the occurrence of headache (common) and dizziness (less common).
  • Immune system disorders and Skin and subcutaneous tissue disorders may manifest as allergic reactions or a skin rash, respectively.
  • Investigations have noted rare occurrences of elevated amino acids in the plasma, and minor, non-specific increases in certain plasma markers like Aspartate Amino Transferase (AST) have been observed.

Reported adverse events typically occur randomly and have been shown to resolve even with the continuation of supplementation.

Safety Considerations and Restrictions

L-Threonine is subject to regulatory restrictions for certain patient groups and conditions:

  • Contraindications are listed for individuals with known hypersensitivity to threonine, chronic kidney disease or kidney failure, chronic liver disorder, or underlying severe metabolic disorders such as homocystinuria or hyperammonemia.
  • Caution is advised for patients with Amyotrophic Lateral Sclerosis (ALS) due to concerns regarding potential effects on lung function.
  • Safety has not been reliably established for use during pregnancy and breast-feeding when consumed as a supplement beyond amounts normally found in food.
  • Caution is advised regarding use with NMDA antagonists (e.g., certain Alzheimer's medications), as L-Threonine may decrease the therapeutic effectiveness of these agents.
Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory assessments classify L-Threonine, an essential amino acid, as a substance with a low potential for acute toxicity following oral ingestion. Official regulatory documents consistently note that the risk of severe, life-threatening outcomes, such as cardiovascular or neurological complications, is not documented in its toxicity profile. The substance is not classified as acutely toxic or corrosive.

Exposure to excessive supplemental quantities may be associated with the occurrence of non-specific discomforts, including stomach upset, headache, nausea, or a skin rash. These effects reflect high-level intake but are not recognized as formal acute overdose symptoms, and symptomatic and supportive treatment remains the expected regulatory standard of care.

Overdose Status Regulator-Documented Finding
Severity Classification Not classified as acutely toxic or corrosive.
Antidote Availability No specific antidote is known.

Emergency actions mandated by regulatory-aligned safety information include rinsing the mouth immediately and not inducing vomiting. Individuals are instructed to seek immediate medical advice or attention if you feel unwell or if any associated adverse symptoms persist following excessive consumption.

Advertisements

Therapeutic Uses of L-Threonine

What L-Threonine Treats: Main Uses and Benefits

L-Threonine is commonly used in areas where short-term symptom management is appropriate, applied across domains where additional symptomatic support is needed. The supportive use of components like L-Threonine in therapeutic mixtures for managing acute conditions contributes to easing the overall symptom load when applied in scenarios where additional management of discomfort is required.

It is commonly used across conditions presenting with acute episodes or situations involving recurrent or episodic manifestations, which include symptoms that create noticeable physiological strain or interfere with daily functioning. It may assist with managing symptom clusters that may become intense or disruptive, and may assist in providing supportive relief.

“It assists with maintaining functional stability and supports the patient during difficult episodes by easing distress.”

It is relevant for easing symptoms that interfere with daily comfort, and contributes to maintaining a sense of stability when symptoms are more noticeable.


Quick Fact: Support for Symptom Clusters

Regulatory References

  1. European Medicines Agency (EMA) summary
Advertisements

Eligibility and Restrictions for Use

L-Threonine's eligibility profile reflects its status as an Essential Amino Acid and a Generally Recognized as Safe (GRAS) substance for nutritional purposes, as defined by regulatory bodies.


Contraindications and Restrictions

The use of L-Threonine is contraindicated for individuals with a known hypersensitivity to the substance. It is also strictly prohibited in patients diagnosed with specific inborn amino acid metabolic disorders, such as Homocystinuria or Maple Syrup Urine Disease, where the degradation of threonine is impaired.

Conditional and Non-Established Use

  • Established Use: L-Threonine use is generally established for the healthy adult population for nutritional support.
  • Conditional Use: Patients with severe hepatic impairment or severe renal impairment require conditional use and potential dosage adjustment due to the crucial role these organs play in amino acid processing. Furthermore, when L-Threonine is provided as a nutrient in special dietary foods, its administration is restricted to being solely under medical supervision (FDA eCFR 21 CFR 172.320(f)).
  • Use Not Established: Supplemental use in the pediatric population is classified as not established by regulatory agencies. Similarly, supplemental use during pregnancy and breastfeeding is categorized as safety not established due to insufficient reliable data.
Advertisements

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for L-Threonine

Interaction Scope

Category Official Regulatory Information
Medicinal product categories with documented interactions NMDA Receptor Antagonists (e.g., Alzheimer’s disease treatments); Intravenous Additives (Calcium and Phosphate ions).
Specific interacting medicines (if explicitly listed) Memantine (listed as an example of an NMDA antagonist).
Mechanistic basis of interactions (only if stated in label) None stated using explicit terms like CYP enzymes or P-gp transporters.
Timing-based interaction rules (if applicable) For intravenous administration, calcium and phosphate ions must be carefully added to alternate infusate bottles to avoid the risk of precipitation.
Population-specific interaction notes (if applicable) IV use is Contraindicated in patients with Inborn Errors of Amino Acid Metabolism; Hepatic Insufficiency requires conservative dosing of L-Threonine-containing solutions due to potential for imbalance.
Interaction-related restrictions Caution is formally advised against co-administration with NMDA receptor antagonists due to the potential to decrease the therapeutic effect of the antagonist.

Interaction Classifications (High-Level)

Classification Official Regulatory Information
Interaction severity classification (as defined in official documents) Use with caution (Pharmacodynamic interaction); Contraindication (Metabolic/Population-specific restriction); Physicochemical Incompatibility (IV Additive).
Regulatory basis (EMA / FDA / etc.) Information derived from FDA Prescribing Information and NIH / MedlinePlus Monographs.
Interaction-context constraints (as defined in official documents) Interactions are context-dependent, applying either to the oral supplement form (pharmacodynamic caution) or the intravenous solution form (physicochemical and metabolic restrictions).

Resulting Interaction Structure

Official interaction statements:

  • Co-administration with NMDA receptor antagonists (e.g., Memantine) may decrease the therapeutic effectiveness of the antagonist, warranting a formal caution against co-use.
  • The use of intravenous solutions containing L-Threonine is Contraindicated in patients with inborn errors of amino acid metabolism.
  • For compounding intravenous solutions, calcium and phosphate ions must be added to alternate infusate bottles to prevent the formal risk of calcium phosphate precipitation.
  • Caution is advised in patients with hepatic insufficiency regarding the administration of L-Threonine-containing solutions due to the risk of plasma amino acid imbalances.

Connection to the overall interaction profile (2–4 sentences):

Regulatory documents define L-Threonine's interaction structure based on its essential amino acid status and the mode of delivery. The profile notes a pharmacodynamic caution with specific central nervous system agents and establishes physicochemical incompatibility rules and metabolic-based contraindications specific to the intravenous solution forms. These statements delineate specific conditions and substances that officially constrain or prohibit co-administration as documented in government labeling.

Advertisements

Mechanism of Action

Structural Role and Protein Synthesis

L-Threonine is an alpha-amino acid that functions as a required structural component in the biosynthesis of various proteins. Specifically, it serves as an essential building block in the formation of collagen and elastin. These proteins maintain the structure and integrity of connective tissues throughout the body.

Catabolism and Glycine Precursors

L-Threonine is catabolized through enzymatic pathways, primarily via threonine dehydrogenase (TDH) and threonine aldolase. The action of threonine aldolase yields the amino acid glycine. Glycine functions as a key precursor in the synthesis of purine and heme molecules, and is involved in inhibitory neurotransmission within the central nervous system (CNS) pathways.

Post-Translational Modification

Threonine residues within proteins are targets for O-glycosylation, a post-translational modification catalyzed by glycosyltransferases. This process affects protein folding, stability, and cellular communication, particularly in the formation of highly glycosylated mucin proteins. Furthermore, L-Threonine is a substrate that enters the cellular one-carbon metabolism pathway.

Advertisements

Dosage and Administration Information

How to use L-Threonine: Official Administration Guidelines

L-Threonine is an essential amino acid utilized in human nutrition and as a component of complex medical solutions. Instructions for its use vary strictly according to the route of administration, which is typically Oral for dietary supplementation or Intravenous (IV) as part of total parenteral nutrition (TPN).


Administration Protocol

Scope Official Guideline
Route of Administration Oral (Dietary/Supplement) or Intravenous (IV) (Parenteral Nutrition)
Dosing Schedule Dosing is determined by overall nutritional requirement. The estimated mean adult requirement is 15 mg/kg body weight/day. IV administration uses a specific concentration within a complete amino acid solution, tailored to metabolic needs and clinical status.
Timing Oral administration is generally with meals or in combination with other nutrients to ensure proper absorption and utilization.
Preparation Requirements For IV administration, the L-Threonine-containing amino acid solution must be sterile and inspected for clarity prior to mixing with dextrose and lipid emulsions (All-in-One solutions). Use only if the solution is clear and contains no particulate matter.
Age-Group Rules Infant and Pediatric IV Use: Requirements must be carefully adjusted based on age and body weight, and may differ significantly from oral requirements.
Missed-Dose Not specified for a single dose of L-Threonine; administration follows the schedule of the broader nutritional regimen (daily for supplements, continuous/daily for TPN).

Official Procedural Steps

The administration of L-Threonine as a parenteral component is a monitored procedure. The final amino acid solution must be administered intravenously through a central or peripheral venous catheter. The infusion must be regulated to deliver the prescribed volume over a full 24-hour cycle or as directed by the prescribing physician. Frequent clinical evaluation and laboratory determinations are required throughout the course of total parenteral nutrition to monitor nitrogen balance and patient tolerance.

Advertisements

Recent Clinical Evidence

L-Threonine: Recent Clinical Evidence


Evidence for Supporting General Nutritional Status

L-Threonine is known as an essential amino acid, meaning the human body must obtain it through diet. Researchers have performed various studies to understand its basic role in the body and to describe its overall characteristics. The primary research in this area consists of Randomized Controlled Trials (RCTs) applied in studies examining patient-reported experiences and basic physiological measures. These studies were mainly conducted on healthy adult males to measure how the body manages L-Threonine.

Studies monitored the amino acid and described specific measurements related to the body’s handling and utilization of L-Threonine following ingestion. Research reports also highlight changes measured during the study period to establish patterns of tolerability in the study populations. Data show patterns related to nutritional requirements based on established methods. Long-term effects on overall well-being or physiological patterns are not fully established by controlled studies extending beyond a few months.


Evidence in Supportive Management of Neurological Symptoms

L-Threonine was evaluated in studies examining symptoms in conditions characterized by functional limitations, particularly those involving muscle spasticity and related motor impairment. The research in this area often used double-blind, placebo-controlled crossover RCTs, which are designed to explore differences between L-Threonine and an inactive substance (placebo). The studies primarily explored short-term symptom changes in adults diagnosed with conditions like Familial Spastic Paraparesis (FSP).

The studies reported how symptoms evolved in the observed populations by monitoring changes in objective scales for muscle tone. Findings were mixed across these trials. Some research highlighted changes measured during the short study period, while other studies indicated that observed shifts in objective measures did not correspond to changes in subjective patient or physician global assessments. Evidence in this area is limited, as the sample sizes were modest and the follow-up durations were restricted to the short-term.


What Research Still Needs to Clarify about L-Threonine

Research highlights several areas where further investigation is needed. The sample sizes were modest in many of the studies exploring neurological symptoms, contributing to the finding that certainty remains low. Furthermore, comparative evidence that evaluates L-Threonine against other established supportive approaches is currently lacking. There is a substantial need for dedicated, long-term interventional studies that monitor responses over defined time intervals and focus on measuring outcomes related to functional balance rather than just physiological absorption.

Key Studies & References

  1. L-threonine in the treatment of familial spastic paraparesis: a double-blind, crossover trial
  2. Nutritional support in high-risk patients: a systematic review and meta-analysis of randomized controlled trials
Advertisements

Frequently Asked Questions (FAQ)

Common questions about L-Threonine (FAQ)

Q: Does L-Threonine affect the levels of other neurotransmitters like Glycine or Serine?

Official information describes L-Threonine as a precursor molecule. This means it is a required starting material for the body's synthesis of other amino acids, including glycine and serine, which are known to be involved in nervous system function. By supporting the creation of these compounds, L-Threonine plays an indirect role in certain nervous system pathways.

Q: Are there any widely known drug interactions with L-Threonine?

Regulatory documents list specific cautions regarding L-Threonine. Caution is advised against co-administration with certain agents, such as NMDA receptor antagonists (e.g., specific Alzheimer’s medications). Furthermore, the intravenous use of L-Threonine is strictly contraindicated (prohibited) in patients with known inborn errors of amino acid metabolism.

Q: Are there any research studies that have examined the effect of L-Threonine on muscle spasticity?

Yes, research has evaluated L-Threonine in studies examining symptoms in neurological conditions, particularly those characterized by muscle spasticity and related motor impairment. Official summaries of this research indicate that the findings across the short-term trials were mixed.

Q: Is L-Threonine ever used to support the body during wound healing or trauma?

L-Threonine is essential because it is a fundamental building block for proteins like collagen, which is necessary for the body's processes of tissue synthesis and maintenance. It is also routinely utilized as a component in Intravenous (IV) nutritional support provided to patients in clinical settings.

Q: Does L-Threonine have a specific role in supporting the intestinal barrier function?

L-Threonine is a required element for synthesizing mucin proteins. These proteins are key components of the mucous secretions that form a component of the mucus barrier over the entire intestinal lining, contributing to the digestive tract's barrier function.

Q: Is L-Threonine supplementation intended to replace a protein-rich diet?

L-Threonine is classified as an essential nutrient, meaning the body must obtain it from diet or supplementation. Supplements are regulated as products intended to support overall nutritional intake, not as a replacement for the broad nutritional benefits found in a protein-rich diet.

Q: Can L-Threonine be found in both animal and plant-based foods?

Yes. As a fundamental nutrient, L-Threonine is found naturally in a wide variety of proteins. Official food composition databases confirm its presence in proteins derived from both animal sources (such as meat, fish, and dairy) and plant sources (such as legumes and seeds).

Q: What are some common foods that contain a high amount of L-Threonine?

Official food composition databases list L-Threonine in many high-protein sources. These include meat, fish, eggs, and dairy products. It is also found in plant-based sources like certain legumes and seeds.

Q: What is the purpose of L-Threonine in the body's nervous system?

In the body, L-Threonine serves as a metabolic precursor used to produce the amino acid glycine, which functions as an inhibitory neurotransmitter that helps regulate communication within certain pathways of the central nervous system.

Q: Can L-Threonine affect the absorption or effects of other amino acids?

Regulatory guidance for intravenous nutritional support (TPN) highlights the necessity of a carefully balanced ratio of all amino acids. This is intended to ensure proper overall nutrient utilization and to avoid imbalances that could potentially affect the body's processing of other amino acids.

Q: What is meant by the statement that L-Threonine supports the immune system?

Official sources describe L-Threonine's functional role as a necessary building block for proteins. This includes proteins involved in the immune response, such as the production of specific antibodies and other related immune system components.

Q: Is L-Threonine involved in fat metabolism or preventing fat buildup in the liver?

L-Threonine is classified as an amino acid involved in the process of fat metabolism. In conjunction with other lipotropic compounds, it helps the body process fat and is utilized in processes that support liver function.

Q: Is L-Threonine used in parenteral nutrition (IV feeding) for patients in a clinical setting?

Yes, L-Threonine is an essential amino acid and is a required ingredient in sterile, intravenous solutions. It is administered in clinical settings as a key nutrient within Total Parenteral Nutrition (TPN) for patients unable to receive adequate nutrition orally.

Q: What kind of evidence exists regarding L-Threonine's effect on mood or anxiety?

The research on L-Threonine's central nervous system role has primarily focused on its function as a precursor to the inhibitory neurotransmitter glycine. However, official summaries of clinical evidence do not establish specific effects on mood or anxiety in human populations.

Q: How does the body's need for L-Threonine change with age or physical activity?

The estimated nutritional requirement for L-Threonine, as defined by international health organizations, is based on factors including age and body weight. These requirements, often expressed per kilogram of body weight, are established to be different for infants and children than for adults.

Q: Is there a known condition called Threonine deficiency?

L-Threonine is categorized as an essential nutrient, meaning the body needs a consistent supply through diet or supplementation. Official nutritional texts do describe deficiency states that can theoretically occur when the intake of any essential amino acid is critically low.

Q: Is it true that L-Threonine can be helpful for maintaining the health of the liver?

L-Threonine's metabolism is closely tied to liver function, which is why official warnings exist regarding use in patients with severe hepatic impairment. Its role as a lipotropic compound means it assists the body in processing fats, a function utilized in the maintenance of liver processing.

Q: Is L-Threonine broken down by the body in the same way as other essential amino acids?

L-Threonine follows specific enzymatic pathways for its breakdown, which are different from other amino acids. Its catabolism is carried out by enzymes such as threonine dehydrogenase and threonine aldolase, distinguishing its metabolism from that of many other essential amino acids.

Q: How does L-Threonine relate to the concept of neuroprotection in research?

Research on L-Threonine has examined its role in the central nervous system, particularly in relation to the synthesis of glycine. Glycine itself is an amino acid that has been explored in studies concerning the protection of nerve cells.

Q: Is there a difference in effect between L-Threonine from food and L-Threonine from a supplement?

Supplements typically provide L-Threonine in its free-form (unbound to protein), which allows for rapid absorption into the bloodstream. In contrast, L-Threonine from whole food protein must first be broken down by the digestive process, resulting in slower absorption.

Q: Do people typically take L-Threonine alone or as part of a multi-amino acid supplement?

L-Threonine is supplied and regulated in markets both as a single-ingredient supplement and as an essential component within multi-amino acid mixtures. It is also a required ingredient in complex intravenous nutritional solutions.

Q: Is there any research on L-Threonine's role in dental health or bone density?

Official information defines L-Threonine as an essential building block for collagen. Collagen is a structural protein necessary for maintaining the integrity of bones and connective tissue throughout the body, including structures that support dental health.

Q: What does it mean if my blood test results show high or low levels of L-Threonine?

Official laboratory information states that elevated levels of an amino acid may indicate an issue with the body's ability to properly metabolize that specific compound. This is considered a key marker when evaluating for possible inborn errors of amino acid metabolism.

Q: Is the stability of L-Threonine affected by temperature or storage conditions?

Yes. Official storage guidelines require L-Threonine to be kept at a Controlled Room Temperature (CRT) and protected in a tightly closed container. These conditions are mandatory to ensure the product's chemical stability and shelf-life.

Q: What is the significance of L-Threonine in maintaining muscle tissue?

L-Threonine is classified as an essential amino acid and is a fundamental element that the body must use to synthesize all necessary proteins. This includes the proteins that are required building blocks for proteins involved in the structure and maintenance of muscle tissue.

Q: How does L-Threonine contribute to a healthy digestive tract?

L-Threonine contributes to the integrity of the digestive tract by providing the necessary building blocks for mucin proteins. These mucin proteins form a critical component of the mucus barrier lining the intestines, which supports the physical integrity of the digestive tract.

Q: Do clinical reports mention any change in lung function related to L-Threonine use in certain populations?

Official safety warnings advise caution for patients with specific neurological conditions, such as Amyotrophic Lateral Sclerosis (ALS). This caution is documented due to concerns regarding the potential for L-Threonine to affect lung function in this vulnerable population.

Advertisements

How should L-Threonine be stored and disposed of?

How to Store and Dispose of L-Threonine

L-Threonine must be stored at Controlled Room Temperature (CRT), typically defined as 20 C to 25 C (68 F to 77 F). The product must be protected from environmental factors and must be kept in a tightly closed container and the original container to maintain stability.

Protection and Safety

It is a mandatory regulatory requirement to keep L-Threonine out of the sight and reach of children.

Disposal Instructions

Unused or expired L-Threonine must be disposed of in accordance with local requirements and regulations. Official instructions prohibit discarding the product in household trash or pouring it down a sink or toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of L-Threonine found in:

A-Z Index: